SO
Nxera Pharma Co., Ltd.
SOLTF · OTC
$7.37 -8.56% (-$0.69)
1M +7.59%
Market Cap ¥71.5B
P/E Ratio -
Div. Yield -
ROE 12.22%
Bulios Fair Price
$4.32
41.4% downside
Trenutna cena
$7.37
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SOLTF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
25 /100
Expensive EV/EBITDA 38.77x
P/S 2.13x
P/FCF 415.69x
Growth
85 /100
Growing Rev. growth 23.94%
Book val. growth 1.76%
EPS growth N/A
Profitability
23 /100
Weak Gross margin 76.04%
Net margin 23.31%
FCF margin 0.51%
Quality
3 /100
Poor ROIC 1.41%
ROE 12.22%
Asset turnover 0.26x
Debt
33 /100
High Debt/Equity 0.84x
Current ratio 2.66x
Net debt/EBITDA 13.07x
Stability
2 /100
Unstable Beta 0.22x
Rev. volatility 77.76%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SOLTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher Cargill
Employees
382
Headquarters
Tokyo
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report